169 related articles for article (PubMed ID: 9403048)
21. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP
J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513
[TBL] [Abstract][Full Text] [Related]
22. Laryngeal radionecrosis versus recurrent cancer: a clinical approach.
McGuirt WF; Greven KM; Keyes JW; Williams DW; Watson N
Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):293-6. PubMed ID: 9557763
[TBL] [Abstract][Full Text] [Related]
23. PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
Sistonen HJ; Ilmarinen T; Atula T; Aro K; Schildt J; Markkola A
BMC Cancer; 2023 Apr; 23(1):358. PubMed ID: 37072716
[TBL] [Abstract][Full Text] [Related]
24. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
25. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
[TBL] [Abstract][Full Text] [Related]
26. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Bredella MA; Caputo GR; Steinbach LS
AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
[TBL] [Abstract][Full Text] [Related]
27. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
28. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
29. 18F-fluorodeoxyglucose-positron emission tomography in the characterization of suspected rhabdoid renal tumor recurrence: a case report.
Pirro V; Skanjeti A; Pelosi E
J Pediatr Hematol Oncol; 2007 Jan; 29(1):69-71. PubMed ID: 17230072
[TBL] [Abstract][Full Text] [Related]
30. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?
Ricci PE; Karis JP; Heiserman JE; Fram EK; Bice AN; Drayer BP
AJNR Am J Neuroradiol; 1998 Mar; 19(3):407-13. PubMed ID: 9541290
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Warshavsky A; Holan A; Muhanna N; Oestraicher Y; Nachalon Y; Kampel L; Nard-Carmel N; Chaushu H; Shapira U; Ungar O; Gutfeld O; Ospovat I; Oz YN; Even-Sapir E; Horowitz G
Head Neck; 2023 Jan; 45(1):207-211. PubMed ID: 36301004
[TBL] [Abstract][Full Text] [Related]
33. Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology.
Kim EE
Int J Gynecol Cancer; 2004; 14(1):12-22. PubMed ID: 14764025
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography in the evaluation of laryngeal carcinoma.
McGuirt WF; Greven KM; Keyes JW; Williams DW; Watson NE; Geisinger KR; Cappellari JO
Ann Otol Rhinol Laryngol; 1995 Apr; 104(4 Pt 1):274-8. PubMed ID: 7717616
[TBL] [Abstract][Full Text] [Related]
35. Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx.
Lee M; Ramaswamy MR; Lilien DL; Nathan CO
Ann Otol Rhinol Laryngol; 2005 Mar; 114(3):202-6. PubMed ID: 15825569
[TBL] [Abstract][Full Text] [Related]
36. [Positron emission tomography in head and neck oncology].
Foehrenbach H; Conessa C; Maszelin P; Kossowski M; Poncet JL; Gaillard JF
Ann Otolaryngol Chir Cervicofac; 2001 Dec; 118(6):365-72. PubMed ID: 11908338
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography (PET)--measured biochemical response to radiotherapy of laryngeal tumors.
Macapinlac HA; Larson SM
Cancer J Sci Am; 1997; 3(6):333-5. PubMed ID: 9403044
[No Abstract] [Full Text] [Related]
38. The usefulness of a repeat study for differentiating between bowel activity and local tumor recurrence on FDG PET scans.
Chun H; Kim CK; Krynckyi BR; Machac J
Clin Nucl Med; 2003 Aug; 28(8):672-3. PubMed ID: 12897657
[TBL] [Abstract][Full Text] [Related]
39. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
van der Putten L; Hoekstra OS; de Bree R; Kuik DJ; Comans EF; Langendijk JA; Leemans CR
Mol Imaging Biol; 2008 Sep; 10(5):294-303. PubMed ID: 18622649
[TBL] [Abstract][Full Text] [Related]
40. An analysis of true- and false-positive results of vocal fold uptake in positron emission tomography-computed tomography imaging.
Seymour N; Burkill G; Harries M
J Laryngol Otol; 2018 Mar; 132(3):270-274. PubMed ID: 29248017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
